LeBar James 4
4 · Zomedica Pharmaceuticals Corp. · Filed Mar 27, 2018
Insider Transaction Report
Form 4
LeBar James
Director
Transactions
- Exercise/Conversion
Common Shares, without par value
2018-01-24$0.20/sh+100,000$20,000→ 220,000 total - Exercise/Conversion
Stock Option (right to buy)
2018-01-24−100,000→ 0 totalExercise: $0.20From: 2016-03-28Exp: 2018-04-21→ Common Shares, without par value (100,000 underlying)
Footnotes (1)
- [F1]The options vested upon grant. The option is currently fully vested.